National Institute on Drug Abuse, Contracts Management Branch, Parklawn Building, Room 10-49, 5600 Fishers Lane, Rockville, MD 20857

A -- QUANTITATIVE ANALYSIS OF AND METHOD DEVELOPMENT FOR CANNABINOIDS, ENDOGENOUS COMPOUNDS, AND OTHER DRUGS OF ABUSE AND RELATED COMPOUNDS BY RADIOIMMUNOASSAY OR RELATED METHODS SOL N01DA-7-7066 DUE 101597 POC Patricia W. Mummaugh, Contract Specialist (301-443-1301), Nikki A. Zangwill, Contracting Officer (301-443-1301) The National Institute of Health (NIH), National Institute on Drug Abuse (NIDA), is soliciting proposals from qualified organizations having the capability to (1) develop analytical assays by radioimmunioassay (RIA) or any related methods for cannabinoids, anandamide, orphanin FQ (nociceptin), and other drugs of abuse and related compounds; (2) to assist research investigators in analyzing their research samples for aforesaid drugs; and (3) to supply assay kits to those researchers who would like to perform assays in their own laboratories. The sample analysis, maintenance of kits in adequate numbers and their shipping shall be performed as designated by NIDA. Offerors must possess the equipment, facilities, and extensive experience with developing radioimmunoassays and/or related assays for various drugs in general, and desired drugs in particular for this contract. It is anticipated that a five-year, incrementally funded, cost-reimbursement-type (completion) contract will be awarded with five one-year options. RFP No. N01DA-7-7066 will be available electronically on or about September 1, 1997 and may be accessed through the NIH Gopher and/or the Internet by using the following electronic mail addresses and instruction: 1) NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov . Once you are at the NIH Home Page, select "Grants and Contracts"; select "NIH Gopher directory: listed under the "Contracts Page" section. Once at the NIH R&D Gopher, select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7-7066". (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp) 2) NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70 (you should now be in the NIH Gopher). Select "Grant and Research Information"; select "R&D Request for Proposals (RFP)"; select "RFPs Available"; select "NIDA"; and, select "RFP N01DA-7-7066". Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualifications, Technical Evaluation Criteria, and proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, offerors comprising the competitive range may be requested to provide additional documentation to the Contracting Officer. Response to this RFP will be due on or about October 15, 1997. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Patricia W. Mummaugh, Contract Specialist Electronic Mail Address: pm69j@nih.gov Telephone: (301) 443-1301 Fax: (301) 443-7595The National Institute of Health (NIH), National Institute on Drug Abuse (NIDA), is soliciting proposals from qualified organizations having the capability to (1) develop analytical assays by radioimmunioassay (RIA) or any related methods for cannabinoids, anandamide, orphanin FQ (nociceptin), and other drugs of abuse and related compounds; (2) to assist research investigators in analyzing their research samples for aforesaid drugs; and (3) to supply assay kits to those researchers who would like to perform assays in their own laboratories. The sample analysis, maintenance of kits in adequate numbers and their shipping shall be performed as designated by NIDA. Offerors must possess the equipment, facilities, and extensive experience with developing radioimmunoassays and/or related assays for various drugs in general, and desired drugs in particular for this contract. It is anticipated that a five-year, incrementally funded, cost-reimbursement-type (completion) contract will be awarded with five one-year options. RFP No. N01DA-7-7066 will be available electronically on or about September 1, 1997 and may be accessed through the NIH Gopher and/or the Internet by using the following electronic mail addresses and instruction: 1) NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov . Once you are at the NIH Home Page, select "Grants and Contracts"; select "NIH Gopher directory: listed under the "Contracts Page" section. Once at the NIH R&D Gopher, select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7-7066". (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp) 2) NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70 (you should now be in the NIH Gopher). Select "Grant and Research Information"; select "R&D Request for Proposals (RFP)"; select "RFPs Available"; select "NIDA"; and, select "RFP N01DA-7-7066". Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualifications, Technical Evaluation Criteria, and proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, offerors comprising the competitive range may be requested to provide additional documentation to the Contracting Officer. Response to this RFP will be due on or about October 15, 1997. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Patricia W. Mummaugh, Contract Specialist Electronic Mail Address: pm69j@nih.gov Telephone: (301) 443-1301 Fax: (301) 443-7595The National Institute of Health (NIH), National Institute on Drug Abuse (NIDA), is soliciting proposals from qualified organizations having the capability to (1) develop analytical assays by radioimmunioassay (RIA) or any related methods for cannabinoids, anandamide, orphanin FQ (nociceptin), and other drugs of abuse and related compounds; (2) to assist research investigators in analyzing their research samples for aforesaid drugs; and (3) to supply assay kits to those researchers who would like to perform assays in their own laboratories. The sample analysis, maintenance of kits in adequate numbers and their shipping shall be performed as designated by NIDA. Offerors must possess the equipment, facilities, and extensive experience with developing radioimmunoassays and/or related assays for various drugs in general, and desired drugs in particular for this contract. It is anticipated that a five-year, incrementally funded, cost-reimbursement-type (completion) contract will be awarded with five one-year options. RFP No. N01DA-7-7066 will be available electronically on or about September 1, 1997 and may be accessed through the NIH Gopher and/or the Internet by using the following electronic mail addresses and instruction: 1) NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov . Once you are at the NIH Home Page, select "Grants and Contracts"; select "NIH Gopher directory: listed under the "Contracts Page" section. Once at the NIH R&D Gopher, select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7-7066". (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp) 2) NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70 (you should now be in the NIH Gopher). Select "Grant and Research Information"; select "R&D Request for Proposals (RFP)"; select "RFPs Available"; select "NIDA"; and, select "RFP N01DA-7-7066". Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualifications, Technical Evaluation Criteria, and proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, offerors comprising the competitive range may be requested to provide additional documentation to the Contracting Officer. Response to this RFP will be due on or about October 15, 1997. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Patricia W. Mummaugh, Contract Specialist Electronic Mail Address: pm69j@nih.gov Telephone: (301) 443-1301 Fax: (301) 443-7595The National Institute of Health (NIH), National Institute on Drug Abuse (NIDA), is soliciting proposals from qualified organizations having the capability to (1) develop analytical assays by radioimmunioassay (RIA) or any related methods for cannabinoids, anandamide, orphanin FQ (nociceptin), and other drugs of abuse and related compounds; (2) to assist research investigators in analyzing their research samples for aforesaid drugs; and (3) to supply assay kits to those researchers who would like to perform assays in their own laboratories. The sample analysis, maintenance of kits in adequate numbers and their shipping shall be performed as designated by NIDA. Offerors must possess the equipment, facilities, and extensive experience with developing radioimmunoassays and/or related assays for various drugs in general, and desired drugs in particular for this contract. It is anticipated that a five-year, incrementally funded, cost-reimbursement-type (completion) contract will be awarded with five one-year options. RFP No. N01DA-7-7066 will be available electronically on or about September 1, 1997 and may be accessed through the NIH Gopher and/or the Internet by using the following electronic mail addresses and instruction: 1) NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov . Once you are at the NIH Home Page, select "Grants and Contracts"; select "NIH Gopher directory: listed under the "Contracts Page" section. Once at the NIH R&D Gopher, select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7-7066". (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp) 2) NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70 (you should now be in the NIH Gopher). Select "Grant and Research Information"; select "R&D Request for Proposals (RFP)"; select "RFPs Available"; select "NIDA"; and, select "RFP N01DA-7-7066". Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualifications, Technical Evaluation Criteria, and proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, offerors comprising the competitive range may be requested to provide additional documentation to the Contracting Officer. Response to this RFP will be due on or about October 15, 1997. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Patricia W. Mummaugh, Contract Specialist Electronic Mail Address: pm69j@nih.gov Telephone: (301) 443-1301 Fax: (301) 443-7595The National Institute of Health (NIH), National Institute on Drug Abuse (NIDA), is soliciting proposals from qualified organizations having the capability to (1) develop analytical assays by radioimmunioassay (RIA) or any related methods for cannabinoids, anandamide, orphanin FQ (nociceptin), and other drugs of abuse and related compounds; (2) to assist research investigators in analyzing their research samples for aforesaid drugs; and (3) to supply assay kits to those researchers who would like to perform assays in their own laboratories. The sample analysis, maintenance of kits in adequate numbers and their shipping shall be performed as designated by NIDA. Offerors must possess the equipment, facilities, and extensive experience with developing radioimmunoassays and/or related assays for various drugs in general, and desired drugs in particular for this contract. It is anticipated that a five-year, incrementally funded, cost-reimbursement-type (completion) contract will be awarded with five one-year options. RFP No. N01DA-7-7066 will be available electronically on or about September 1, 1997 and may be accessed through the NIH Gopher and/or the Internet by using the following electronic mail addresses and instruction: 1) NIH Home Page (via the World Wide Web): Access the NIH Home Page by using http://www.nih.gov . Once you are at the NIH Home Page, select "Grants and Contracts"; select "NIH Gopher directory: listed under the "Contracts Page" section. Once at the NIH R&D Gopher, select "RFPs Available"; select "NIDA"; and select "RFP N01DA-7-7066". (URL: gopher://gopher.nih.gov:70/11/res/rd-rfp) 2) NIH Gopher: Point your Gopher client to GOPHER.NIH.GOV Port 70 (you should now be in the NIH Gopher). Select "Grant and Research Information"; select "R&D Request for Proposals (RFP)"; select "RFPs Available"; select "NIDA"; and, select "RFP N01DA-7-7066". Please note that the RFP for this acquisition will be streamlined to include only the Work Statement, deliverable and reporting requirements, special requirements and mandatory qualifications, Technical Evaluation Criteria, and proposal preparation instructions. All information required for the submission of an offer will be contained in the electronic RFP package. Following proposal submission and the initial review process, offerors comprising the competitive range may be requested to provide additional documentation to the Contracting Officer. Response to this RFP will be due on or about October 15, 1997. Any responsible offeror may submit a proposal which will be considered by the Government. This advertisement does not commit the Government to award a contract. Point of Contact: Patricia W. Mummaugh, Contract Specialist Electronic Mail Address: pm69j@nih.gov Telephone: (301) 443-1301 Fax: (301) 443-7595 (0210)

Loren Data Corp. http://www.ld.com (SYN# 0005 19970731\A-0005.SOL)